Business Of Biotech
Chart positions today · Philippines
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Business Of Biotech, try…
Ranking history · Philippines
Latest episodes
-
Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D.
October 19, 2026 · 47 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Bret Bostwick, M.D., Venture Partner at Breyer Capital, a family office, talks about his path from medical geneticist to CNS drug…
-
AI, China, And Biotech Investing With SR One's Simeon George, M.D.
October 12, 2026 · 49 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Simeon George, M.D., Cofounder and CEO at SR One Capital Management, returns to the show to talk about how SR One evaluates biotech…
-
Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
October 5, 2026 · 60 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Cyriac Roeding talks about cofounding and leading Earli, a "bioAI" company using synthetic DNA switches and cancer-binding lipid…
-
Growing And Scaling A Radiopharmaceuticals Company With AdvanCell's Philina Lee, Ph.D.
September 28, 2026 · 55 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Philina Lee, Ph.D., CEO at AdvanCell, explains how lead-based targeted alpha therapies can unlock deeper, more durable cancer…
-
Finding New Opportunities In Obesity With Moonwalk Bioscience's Alex Aravanis, M.D., Ph.D.
September 21, 2026 · 47 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Alex Aravanis, M.D., Ph.D., CEO of Moonwalk Biosciences, talks about the opportunity in obesity beyond GLP-1s. He describes…
Show 7 more episodesShow fewer episodes
-
Biotech Finance And Investor Update With Independent Board Director Allan Shaw
September 14, 2026 · 55 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Independent Board Director and five-time public company CFO Alan Shaw returns to the show for an update on current biotech financing…
-
Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig
September 7, 2026 · 56 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, David Craig, Cofounder, President, and CEO at Sarcomatrix, explains why the old biotech playbook breaks down in today’s funding…
-
Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka
August 31, 2026 · 58 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talks about what it really takes for biotech companies to attract capital, stay focused…
-
Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil
August 24, 2026 · 56 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures, describes forming and funding startups and early-stage biotech companies with a…
-
Getting To A First Product Approval With Celcuity's Brian Sullivan
August 17, 2026 · 50 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about winning the company's first FDA approval for Revtorpyk, a kinase inhibitor for breast…
-
Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings
August 10, 2026 · 50 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Paul Hastings, Founding CEO and Board Member at Nkarta, an allogeneic cell therapy developer, talks about building off-the-shelf CAR…
-
A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.
August 3, 2026 · 56 minWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Annette Bakker, Ph.D., CEO at the Children's Tumor Foundation, and Andrew Lo, Ph.D., Finance Professor at MIT's Sloan School of…

United States
Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
South Africa
United Kingdom